scholarly journals Glycine ameliorates lung reperfusion injury after cold preservation in an ex vivo rat lung model

2003 ◽  
Vol 75 (5) ◽  
pp. 591-598 ◽  
Author(s):  
Mitsugu Omasa ◽  
Tatsuo Fukuse ◽  
Shinya Toyokuni ◽  
Yoichi Mizutani ◽  
Hiroshi Yoshida ◽  
...  
PLoS ONE ◽  
2017 ◽  
Vol 12 (3) ◽  
pp. e0171736 ◽  
Author(s):  
Chung-Kan Peng ◽  
Kun-Lun Huang ◽  
Chou-Chin Lan ◽  
Yu-Juei Hsu ◽  
Geng-Chin Wu ◽  
...  

2005 ◽  
Vol 37 (6) ◽  
pp. 348-353 ◽  
Author(s):  
T. Shoji ◽  
M. Omasa ◽  
T. Nakamura ◽  
T. Yoshimura ◽  
H. Yoshida ◽  
...  

2003 ◽  
Vol 35 (1) ◽  
pp. 138-139 ◽  
Author(s):  
M Omasa ◽  
T Fukuse ◽  
K Matsuoka ◽  
K Inui ◽  
S.H Hyon ◽  
...  

2018 ◽  
Vol 33 (1) ◽  
pp. 1-13 ◽  
Author(s):  
Yan Zhou ◽  
Xinqiao Zhou ◽  
Wenjuan Zhou ◽  
Qingfeng Pang ◽  
Zhiping Wang

Blood ◽  
2006 ◽  
Vol 107 (3) ◽  
pp. 1217-1219 ◽  
Author(s):  
Ulrich J. H. Sachs ◽  
Katja Hattar ◽  
Norbert Weissmann ◽  
Rainer M. Bohle ◽  
Timo Weiss ◽  
...  

AbstractTransfusion-related acute lung injury (TRALI) is a hazardous complication of transfusion and has become the leading cause of transfusion-related death in the United States and United Kingdom. Although leukoagglutinating antibodies have been frequently shown to be associated with the syndrome, the mechanism by which they induce TRALI is poorly understood. Therefore, we reproduced TRALI in an ex vivo rat lung model. Our data demonstrate that TRALI induction by antileukocyte antibodies is dependent on the density of the cognate antigen but does not necessarily require leukoagglutinating properties of the antibody or the presence of complement proteins. Rather, antibody-mediated activation of neutrophils seems to initiate TRALI, a process that could be triggered by neutrophil stimulation with fMLP. Antibody-mediated neutrophil activation and subsequent release of reactive oxygen species may thus represent key events in the pathophysiologic cascade that leads to immune TRALI.


1993 ◽  
Vol 41 (05) ◽  
pp. 304-307 ◽  
Author(s):  
N. Ohno ◽  
H. Yokomise ◽  
T. Fukuse ◽  
T. Hirata ◽  
S. Hitomi ◽  
...  

2001 ◽  
Vol 280 (3) ◽  
pp. H1311-H1317 ◽  
Author(s):  
David A. Welsh ◽  
Benoit P. H. Guery ◽  
Bennett P. Deboisblanc ◽  
Elizabeth P. Dobard ◽  
Colette Creusy ◽  
...  

Hydrostatic pulmonary edema is a common complication of congestive heart failure, resulting in substantial morbidity and mortality. Keratinocyte growth factor (KGF) is a mitogen for type II alveolar epithelial and microvascular cells. We utilized the isolated perfused rat lung model to produce hydrostatic pulmonary edema by varying the left atrial and pulmonary capillary pressure. Pretreatment with KGF attenuated hydrostatic edema formation. This was demonstrated by lower wet-to-dry lung weight ratios, histological evidence of less alveolar edema formation, and reduced alveolar accumulation of intravascularly administered FITC-labeled large-molecular-weight dextran in rats pretreated with KGF. Thus KGF attenuates injury in this ex vivo model of hydrostatic pulmonary edema via mechanisms that prevent increases in alveolar-capillary permeability.


2019 ◽  
Vol 157 (1) ◽  
pp. 425-433 ◽  
Author(s):  
Hiromichi Niikawa ◽  
Toshihiro Okamoto ◽  
Kamal S. Ayyat ◽  
Yoshifumi Itoda ◽  
Carol F. Farver ◽  
...  

2020 ◽  
Vol 22 (3) ◽  
Author(s):  
Johanna Eriksson ◽  
Erik Sjögren ◽  
Hans Lennernäs ◽  
Helena Thörn

AbstractThe ex vivo isolated perfused rat lung (IPL) model has been demonstrated to be a useful tool during drug development for studying pulmonary drug absorption. This study aims to investigate the potential use of IPL data to predict rat in vivo lung absorption. Absorption parameters determined from IPL data (ex vivo input parameters) in combination with intravenously determined pharmacokinetic data were used in a biopharmaceutics model to predict experimental rat in vivo plasma concentration-time profiles and lung amount after inhalation of five different inhalation compounds. The performance of simulations using ex vivo input parameters was compared with simulations using in vitro input parameters, to determine whether and to what extent predictability could be improved by using input parameters determined from the more complex ex vivo model. Simulations using ex vivo input parameters were within twofold average difference (AAFE < 2) from experimental in vivo data for all compounds except one. Furthermore, simulations using ex vivo input parameters performed significantly better than simulations using in vitro input parameters in predicting in vivo lung absorption. It could therefore be advantageous to base predictions of drug performance on IPL data rather than on in vitro data during drug development to increase mechanistic understanding of pulmonary drug absorption and to better understand how different substance properties and formulations might affect in vivo behavior of inhalation compounds.


Sign in / Sign up

Export Citation Format

Share Document